Handbook home
Drugs Affecting the Nervous System (PHRM30002)
Undergraduate level 3Points: 12.5On Campus (Parkville)
About this subject
- Overview
- Eligibility and requirements
- Assessment
- Dates and times
- Further information
- Timetable(opens in new window)
Contact information
Semester 2
Subject Coordinator
Assoc Prof Peter Crack
pcrack@unimelb.edu.au
Assoc Prof James Ziogas
jamesz@unimelb.edu.au
Administrative Coordination:
BiomedSci-AcademicServices@unimelb.edu.au
Overview
Availability | Semester 2 |
---|---|
Fees | Look up fees |
The working of the brain and nervous system is an important frontier of modern medicine and nerves are the target for many important drugs. This subject will address how drugs modulate the processes of neuronal communication and survival in the context of the management of mood and emotional disorders, addictive behaviours, neuro-degenerative diseases, pain and epilepsy. This subject will also discuss strategies for the development of future therapeutics. Students will gain an appreciation of how a detailed understanding of pathophysiological processes is important for the rational development of new therapeutics.
Intended learning outcomes
On successful completion of this unit, students will have developed a solid understanding of the nature of and drug treatments for a range of central nervous system diseases. They will have a knowledge of the nature of research into central nervous system disorders and of the therapeutic and the undesirable actions of key therapeutics and recreational drugs. An understanding of how knowledge about pathophysiological processes is important for the rational drug development.
Generic skills
By the end of this unit students will:
- Be adept at learning in a range of ways.
- Be able to examine critically, synthesise and evaluate knowledge pertaining to drugs.
- Have an understanding of the scientific basis of the action of drugs in the central nervous system.
- Be able to integrate key pharmacological and other medical research principles as they relate to neuropharmacology.
- Be adept at critical thinking and problem solving.
- Participate in collaborative learning.
Last updated: 27 April 2024
Eligibility and requirements
Prerequisites
BSc students:
Code | Name | Teaching period | Credit Points |
---|---|---|---|
PHRM20001 | Pharmacology: How Drugs Work | Semester 2 (On Campus - Parkville) |
12.5 |
BBiomed students:
Code | Name | Teaching period | Credit Points |
---|---|---|---|
BIOM20002 | Human Structure and Function | Semester 2 (On Campus - Parkville) |
25 |
Students wishing to undertake this subject as breadth will need the approval of the subject co-ordinator.
Corequisites
None
Non-allowed subjects
This subject cannot be taken if credit has been previously obtained for 534-302 Neuropharmacology.
Inherent requirements (core participation requirements)
The University of Melbourne is committed to providing students with reasonable adjustments to assessment and participation under the Disability Standards for Education (2005), and the Assessment and Results Policy (MPF1326). Students are expected to meet the core participation requirements for their course. These can be viewed under Entry and Participation Requirements for the course outlines in the Handbook.
Further details on how to seek academic adjustments can be found on the Student Equity and Disability Support website: http://services.unimelb.edu.au/student-equity/home
Last updated: 27 April 2024
Assessment
Additional details
- Continuing assessments comprising LMS delivered assessments and a multiple choice question assessment delivered during the semester (30%)
- A 2 hr examination in the examination period (70%)
Last updated: 27 April 2024
Dates & times
- Semester 2
Principal coordinator Peter Crack Coordinator James Ziogas Mode of delivery On Campus (Parkville) Contact hours 3 x one hour lectures per week (total contact hours: 36) Total time commitment 170 hours Teaching period 24 July 2017 to 22 October 2017 Last self-enrol date 4 August 2017 Census date 31 August 2017 Last date to withdraw without fail 22 September 2017 Assessment period ends 17 November 2017 Semester 2 contact information
Subject Coordinator
Assoc Prof Peter Crack
pcrack@unimelb.edu.au
Assoc Prof James Ziogas
jamesz@unimelb.edu.auAdministrative Coordination:
BiomedSci-AcademicServices@unimelb.edu.au
Time commitment details
170 hours
Last updated: 27 April 2024
Further information
- Texts
Prescribed texts
None
Recommended texts and other resources
Nestler, Hymen & Malenka, Molecular Neuropharmacology McGraw Hill.
Golan et al., Principles of Pharmacology, 3rd Edition. Lippincott Williams and Wilkins.
- Subject notes
This subject is available to students enrolled in the BSc, Biomedicine degree.
- Related Handbook entries
This subject contributes to the following:
Type Name Informal specialisation Biomedical Biotechnology Informal specialisation Science-credited subjects - new generation B-SCI and B-ENG. Major Pharmacology Informal specialisation Selective subjects for B-BMED Major Neuroscience Major Neuroscience Informal specialisation Biomedical Biotechnology Major Pharmacology - Breadth options
This subject is available as breadth in the following courses:
- Available through the Community Access Program
About the Community Access Program (CAP)
This subject is available through the Community Access Program (also called Single Subject Studies) which allows you to enrol in single subjects offered by the University of Melbourne, without the commitment required to complete a whole degree.
Entry requirements including prerequisites may apply. Please refer to the CAP applications page for further information.
- Available to Study Abroad and/or Study Exchange Students
This subject is available to students studying at the University from eligible overseas institutions on exchange and study abroad. Students are required to satisfy any listed requirements, such as pre- and co-requisites, for enrolment in the subject.
Last updated: 27 April 2024